Verition Fund Management LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 303 filers reported holding HAEMONETICS CORP in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
Verition Fund Management LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$213,200
+6.4%
2,380
+1.1%
0.00%
-33.3%
Q2 2023$200,420
-35.9%
2,354
-37.7%
0.00%
-25.0%
Q1 2023$312,795
-62.1%
3,780
-49.2%
0.00%
-55.6%
Q1 2021$825,000
-12.9%
7,436
-9.7%
0.01%
-47.1%
Q4 2019$947,000
+110.9%
8,238
+110.3%
0.02%
+6.2%
Q3 2018$449,000
-68.9%
3,917
-75.7%
0.02%
-81.8%
Q2 2018$1,445,000
+462.3%
16,115
+180.8%
0.09%
+319.0%
Q3 2017$257,000
-43.1%
5,738
-49.8%
0.02%
-52.3%
Q2 2017$452,000
+96.5%
11,440
+100.3%
0.04%
+120.0%
Q4 2016$230,0005,7120.02%
Other shareholders
HAEMONETICS CORP shareholders Q1 2023
NameSharesValueWeighting ↓
Millrace Asset Group, Inc. 19,264$1,7262.13%
Parkman Healthcare Partners LLC 88,962$7,969,2161.46%
HEARTLAND ADVISORS INC 256,414$24,435,2741.37%
Riverwater Partners LLC 15,553$1,393,2381.27%
KINGDON CAPITAL MANAGEMENT, L.L.C. 111,100$9,952,3381.15%
Lisanti Capital Growth, LLC 78,425$7,025,3121.11%
Aristotle Capital Boston, LLC 311,666$27,919,0540.90%
ROYCE & ASSOCIATES LP 947,550$84,881,5290.86%
CHASE INVESTMENT COUNSEL CORP 18,770$1,6810.84%
Virtus Investment Advisers, Inc. 13,662$1,223,8420.83%
View complete list of HAEMONETICS CORP shareholders